Home Cart Sign in  
Chemical Structure| 2172652-48-9 Chemical Structure| 2172652-48-9

Structure of Vociprotafib
CAS No.: 2172652-48-9

Chemical Structure| 2172652-48-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

SHP2-IN-7 is an SHP2 inhibitor extracted from patent WO2018013597.

Synonyms: RMC-4630; SHP2-IN-7; SSE15206

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Vociprotafib

CAS No. :2172652-48-9
Formula : C20H27ClN6O2S
M.W : 450.99
SMILES Code : N[C@H]1C2(CO[C@H]1C)CCN(C3=NC(C)=C(SC4=CC=NC(N)=C4Cl)N=C3CO)CC2
Synonyms :
RMC-4630; SHP2-IN-7; SSE15206
MDL No. :N/A

Safety of Vociprotafib

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Related Pathways of Vociprotafib

RTK

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT03634982 Solid Tumors PHASE1 UNKNOWN 2023-05-31 Honor Health Research Institut... More >>e, Scottsdale, Arizona, 85258, United States|City of Hope, Duarte, California, 91010, United States|UC Irvine - Chao Family Comprehensive Cancer Center, Orange, California, 92868, United States|UC Davis Comprehensive Cancer Center, Sacramento, California, 95817, United States|UC San Francisco - Helen Diller Family Comprehensive Cancer Center, San Francisco, California, 94115, United States|University of Colorado Cancer Center, Aurora, Colorado, 80045, United States|Sarah Cannon Research Institute - Florida Cancer Specialists, Sarasota, Florida, 34232, United States|Moffit Cancer Center, Tampa, Florida, 33612, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02215, United States|University of Oklahoma - Stephenson Cancer Center, Oklahoma City, Oklahoma, 73104, United States|Sarah Cannon Research Institute - Tennessee Oncology, PLLC, Nashville, Tennessee, 37203, United States|University of Texas at Austin - Dell Medical School, Austin, Texas, 78712, United States Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.22mL

0.44mL

0.22mL

11.09mL

2.22mL

1.11mL

22.17mL

4.43mL

2.22mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records

Categories